The efficacy and safety of zoledronic acid and strontium-89 in treating non-small cell lung cancer: a systematic review and meta-analysis of randomized controlled trials.
Zhi Gang HuYufeng TianWenxin LiYushu RuanFanjun ZengPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2019)
Our analysis demonstrates that ZA +strontium-89 can be considered a priority for NSCLC patients with bone metastases, followed by ZA.